G. Wilkinson

发表

Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.

K. Coopman, G. Robb, G. Willars, 2011, Molecular endocrinology.

Regulation of the avidity of ternary complexes containing the human 5‐HT1A receptor by mutation of a receptor contact site on the interacting G protein α subunit

G. Milligan, G. Wilkinson, Philip J. Welsby, 2002, British journal of pharmacology.

L. E. Pritchard, A. White, D. Armstrong, 2004, The Journal of endocrinology.

Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists.

G. Milligan, G. Wilkinson, E. Kellett, 2002, Molecular pharmacology.

Full and Partial Agonists of Muscarinic M3 Receptors Reveal Single and Oscillatory Ca2+ Responses by β2-Adrenoceptors

A. Tobin, G. Willars, M. Sullivan, 2009, Journal of Pharmacology and Experimental Therapeutics.

G protein-coupled P2 purinoceptors: from molecular biology to functional responses.

J. T. Turner, G. Weisman, G. Wilkinson, 1995, Trends in pharmacological sciences.

Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (GLP-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent “Compound 2” at the GLP-1 Receptor

K. Coopman, Yan Huang, S. Bradley, 2010, Journal of Pharmacology and Experimental Therapeutics.

Evaluation of the bronchodilator properties of Ro 31–6930, a novel potassium channel opener, in the guinea‐pig

I. Cowlrick, G. Wilkinson, P. Paciorek, 1990, British journal of pharmacology.

Ca2+ signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells

G. Willars, M. I. Christie, G. Wilkinson, 2002, British journal of pharmacology.

Differential heterologous and homologous desensitization of two receptors for ATP (P2y purinoceptors and nucleotide receptors) coexisting on endothelial cells.

G. Wilkinson, J. Purkiss, M. Boarder, 1994, Molecular pharmacology.

Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism

W. Feniuk, G. Wilkinson, P. Humphrey, 1997, British journal of pharmacology.

Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists

D. West, G. Wilkinson, J. Purkiss, 1994, British journal of pharmacology.

Potent antagonism by BIM‐23056 at the human recombinant somatostatin sst5 receptor

W. Feniuk, G. Wilkinson, L. Sellers, 1996, British journal of pharmacology.

Differential regulation of inositol 1,4,5‐trisphosphate by co‐existing P2Y‐purinoceptors and nucleotide receptors on bovine aortic endothelial cells

G. Wilkinson, J. Purkiss, M. Boarder, 1994, British journal of pharmacology.

P2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin.

G. Wilkinson, I. Dainty, K. McKechnie, 1994, The Journal of pharmacology and experimental therapeutics.

Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D

G. Wilkinson, J. Purkiss, M. Boarder, 1993, British journal of pharmacology.

The regulation of aortic endothelial cells by purines and pyrimidines involves co‐existing P2y‐purinoceptors and nucleotide receptors linked to phospholipase C

G. Wilkinson, J. Purkiss, M. Boarder, 1993, British journal of pharmacology.

Binding of [35S]adenosine 5'-O-(2-thiodiphosphate) to endothelial cells in culture.

G. Wilkinson, M. Boarder, 1995, Biochemical pharmacology.

The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities*

Graeme Milligan, G. Milligan, Shirley Wilson, 2005, Journal of Biological Chemistry.

Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+.

Gary B Willars, G. Willars, Tim D Werry, 2003, The Biochemical journal.

Cross Talk between P2Y2 Nucleotide Receptors and CXC Chemokine Receptor 2 Resulting in Enhanced Ca2+ Signaling Involves Enhancement of Phospholipase C Activity and Is Enabled by Incremental Ca2+ Release in Human Embryonic Kidney Cells

G. Willars, G. Wilkinson, Tim D. Werry, 2003, Journal of Pharmacology and Experimental Therapeutics.

Cross Talk between P 2 Y 2 Nucleotide Receptors and CXC Chemokine Receptor 2 Resulting in Enhanced Ca 2 Signaling Involves Enhancement of Phospholipase C Activity and Is Enabled by Incremental Ca 2 Release in Human Embryonic Kidney Cells

G. Willars, G. Wilkinson, Tim D. Werry, 2003 .

Homologous and heterologous desensitisation of somatostatin-induced increases in intracellular Ca2+ and inositol 1,4,5-trisphosphate in CHO-K1 cells expressing human recombinant somatostatin sst5 receptors.

W. Feniuk, P. Humphrey, G. Wilkinson, 1997, European journal of pharmacology.

P2 purinoceptor-stimulated conversion of arginine to citrulline in bovine endothelial cells is reduced by inhibition of protein kinase C.

G. Wilkinson, M. Boarder, V. Patel, 1996, Biochemical pharmacology.

Crosstalk between P2Y 2 nucleotide receptors and CXCR2 resulting in enhanced Ca 2+ signalling involves enhancement of phospholipase C activity, and is enabled by incremental Ca 2+ release in HEK cells*

G. Willars, G. Wilkinson, Tim D. Werry, 2003 .

Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.

K. Coopman, G. Robb, G. Willars, 2011, Molecular endocrinology.